CONAVI MEDICAL CORP (CNVI.CA) Fundamental Analysis & Valuation

TSX-V:CNVI • CA2059531020

Current stock price

0.36 CAD
-0.02 (-5.26%)
Last:

This CNVI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CNVI.CA Profitability Analysis

1.1 Basic Checks

  • CNVI had negative earnings in the past year.
  • In the past year CNVI has reported a negative cash flow from operations.
  • In the past 5 years CNVI reported 4 times negative net income.
  • In the past 5 years CNVI reported 4 times negative operating cash flow.
CNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • CNVI has a worse Return On Assets (-301.00%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -301%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVI.CA Yearly ROA, ROE, ROICCNVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K

1.3 Margins

  • Looking at the Gross Margin, with a value of 83.61%, CNVI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for CNVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNVI.CA Yearly Profit, Operating, Gross MarginsCNVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CNVI.CA Health Analysis

2.1 Basic Checks

  • CNVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CNVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNVI.CA Yearly Shares OutstandingCNVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNVI.CA Yearly Total Debt VS Total AssetsCNVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -38.71, we must say that CNVI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -38.71, CNVI is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -38.71
ROIC/WACCN/A
WACC9.25%
CNVI.CA Yearly LT Debt VS Equity VS FCFCNVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that CNVI may have some problems paying its short term obligations.
  • CNVI has a Current ratio (0.23) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.22 indicates that CNVI may have some problems paying its short term obligations.
  • The Quick ratio of CNVI (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.22
CNVI.CA Yearly Current Assets VS Current LiabilitesCNVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CNVI.CA Growth Analysis

3.1 Past

  • CNVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.02%, which is quite impressive.
  • The Revenue has grown by 1724.40% in the past year. This is a very strong growth!
  • CNVI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.88% yearly.
EPS 1Y (TTM)58.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.95%
Revenue 1Y (TTM)1724.4%
Revenue growth 3Y-30.88%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, CNVI will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.03% on average per year.
  • Based on estimates for the next years, CNVI will show a very strong growth in Revenue. The Revenue will grow by 60.40% on average per year.
EPS Next Y50%
EPS Next 2Y25.5%
EPS Next 3Y17.86%
EPS Next 5Y17.03%
Revenue Next Year-34.34%
Revenue Next 2Y17.31%
Revenue Next 3Y44.8%
Revenue Next 5Y60.4%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNVI.CA Yearly Revenue VS EstimatesCNVI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2024 2025 2026 2027 2028 2029 10M 20M 30M 40M 50M
CNVI.CA Yearly EPS VS EstimatesCNVI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2025 2026 2027 2028 2029 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. CNVI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CNVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CNVI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVI.CA Price Earnings VS Forward Price EarningsCNVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNVI.CA Per share dataCNVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • CNVI's earnings are expected to grow with 17.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.5%
EPS Next 3Y17.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CNVI.CA Dividend Analysis

5.1 Amount

  • No dividends for CNVI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CNVI.CA Fundamentals: All Metrics, Ratios and Statistics

CONAVI MEDICAL CORP

TSX-V:CNVI (3/19/2026, 7:00:00 PM)

0.36

-0.02 (-5.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-26
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap37.23M
Revenue(TTM)9.12M
Net Income(TTM)-20.52M
Analysts80
Price Target1.02 (183.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.09
BVpS-0.26
TBVpS-0.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -301%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.61%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.51%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.22
Altman-Z -38.71
F-Score2
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)85.26%
Cap/Depr(5y)122.76%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.95%
EPS Next Y50%
EPS Next 2Y25.5%
EPS Next 3Y17.86%
EPS Next 5Y17.03%
Revenue 1Y (TTM)1724.4%
Revenue growth 3Y-30.88%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-34.34%
Revenue Next 2Y17.31%
Revenue Next 3Y44.8%
Revenue Next 5Y60.4%
EBIT growth 1Y-220.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-510.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-489.43%
OCF growth 3YN/A
OCF growth 5YN/A

CONAVI MEDICAL CORP / CNVI.CA Fundamental Analysis FAQ

What is the fundamental rating for CNVI stock?

ChartMill assigns a fundamental rating of 2 / 10 to CNVI.CA.


What is the valuation status of CONAVI MEDICAL CORP (CNVI.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CONAVI MEDICAL CORP (CNVI.CA). This can be considered as Overvalued.


How profitable is CONAVI MEDICAL CORP (CNVI.CA) stock?

CONAVI MEDICAL CORP (CNVI.CA) has a profitability rating of 1 / 10.


What is the expected EPS growth for CONAVI MEDICAL CORP (CNVI.CA) stock?

The Earnings per Share (EPS) of CONAVI MEDICAL CORP (CNVI.CA) is expected to grow by 50% in the next year.